Meyka Pro banner
Compass Diversified

Stay Updated with the Latest Compass Diversified CODI-PA News in Real Time

Find CODI-PA news now at Meyka AI. Stay informed with the latest Compass Diversified stocks updates, including price news, market analysis, and expert insights.

CODI-PANYSE
IndustrialsConglomerates
$19.77
$0.07(0.33%)
U.S. Market is Open · 13:37
Honda Rebel 300 Launched at Rs 2.22 Lakh in India on August 26
📅 10 hours ago

Honda Rebel 300 Launched at Rs 2.22 Lakh in India on August 26

Honda Rebel 300 launched in India at Rs 2.22 lakh with 286cc engine and optional e-clutch technology. Bookings open, deliveries from mid-October 2026.

Read more 12
Lego Profit Surges 32% as ‘Stronger Than Expected’ First Half Sets Up Double-Digit 2026 Growth
📅 1 day ago

Lego Profit Surges 32% as ‘Stronger Than Expected’ First Half Sets Up Double-Digit 2026 Growth

Lego posted a 32% jump in first-half net profit on Tuesday, August 25, 2026. The Danish toymaker reported 8.6 billion Danish kroner ($1.34 billion) in profit. CEO Niels Christiansen called results “stronger than expected across the board.” First-Half Results by the Numbers Lego generated record first-half revenue of 41.9 billion Danish kroner ($6.54 billion), up…

Read more 12
Robinhood Stock Rises 4.63% to $95.77 as MSTR, COIN and CRCL Rally on Treasury Buyback
📅 6 days ago

Robinhood Stock Rises 4.63% to $95.77 as MSTR, COIN and CRCL Rally on Treasury Buyback

Robinhood stock closed at $95.77 on August 19, 2026, up 4.63% for the session. Strategy, Coinbase, and Circle all posted stronger gains the same day. The U.S. Treasury’s expanded bond buyback program eased yields and lifted risk appetite across crypto-linked equities. Bitcoin climbed above $68,000, extending gains into $71,600 territory by Thursday morning. Why Robinhood…

Read more 12
Strides Pharma Stock Rallies 10% as USFDA Concludes Bengaluru Inspection
📅 6 days ago

Strides Pharma Stock Rallies 10% as USFDA Concludes Bengaluru Inspection

Strides Pharma shares surged 11% to ₹1,055.90 on the BSE on August 20, 2026. The rally followed news that the company’s flagship Bengaluru facility received a USFDA Establishment Inspection Report. That report confirms successful closure of a cGMP inspection conducted in May 2026. Heavy trading volumes accompanied the sharp intraday move. What the USFDA EIR…

Read more 12
Gaja Alternative IPO GMP Today: How Gaja Capital Is Challenging the AIF Model
📅 6 days ago

Gaja Alternative IPO GMP Today: How Gaja Capital Is Challenging the AIF Model

Gaja Alternative IPO’s Grey Market Premium stood at ₹21 as of Thursday, August 20, 2026, 9:45 AM IST. That implies a listing price near ₹181, a 13% premium over the ₹160 upper band. The ₹550 crore issue from Gaja Capital’s asset management arm closes for subscription on August 21. Overall subscription remained modest at 0.30…

Read more 12
Stellantis Recalls 955,000 Vehicles Over Camera Software Flaw on August 19
📅 7 days ago

Stellantis Recalls 955,000 Vehicles Over Camera Software Flaw on August 19

Stellantis recalls 955,000 vehicles worldwide due to radio software preventing rearview camera display. Fix via over-the-air update starting September. No injuries reported.

Read more 12
Stellantis Recalls 955,000 Vehicles Over Camera Software Flaw on August 18
📅 8 days ago

Stellantis Recalls 955,000 Vehicles Over Camera Software Flaw on August 18

Stellantis recalls 955,000 Chrysler, Jeep, Dodge and Ram vehicles over rearview camera software glitch. Fix via over-the-air update. No injuries reported.

Read more 12
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
📅 9 days ago

AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit

AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review.  This marks AstraZeneca’s second major trial halt…

Read more 12
NSE IPO Listings: Molbio Diagnostics, Dhoot Transmission Debut Today; Check GMPs
📅 9 days ago

NSE IPO Listings: Molbio Diagnostics, Dhoot Transmission Debut Today; Check GMPs

Two new NSE IPO listings hit the market on Monday, August 17, 2026. Molbio Diagnostics and Dhoot Transmission both made their stock market debuts today. Dhoot Transmission shares surged 37.06% on the NSE, opening at ₹1,193.80. Molbio Diagnostics listed with a smaller but solid 21.44% premium at ₹980. Both companies had commanded strong grey market…

Read more 12

CODI-PA News FAQ